CNMD
insider transactionsCONMED Corp — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Director
$0
668 sh
Own New
-
Exercise·M
Director
$0
668 sh
Own +17%
-
Exercise·M
Director
$0
668 sh
Own New
-
Exercise·M
Director
$0
668 sh
Own +4%
-
Exercise·M
Director
$0
668 sh
Own New
-
Exercise·M
Director
$0
668 sh
Own +439%
-
Exercise·M
Director
$0
668 sh
Own New
-
Exercise·M
Director
$0
668 sh
Own +15%
-
Exercise·M
Director
$0
668 sh
Own New
-
Exercise·M
Director
$0
668 sh
Own +4%
-
Grant·A
Director
$0
5.8K sh
Own New
-
Grant·A
Director
$0
5.8K sh
Own New
-
Grant·A
Director
$0
5.8K sh
Own New
-
Grant·A
Director
$0
5.8K sh
Own New
-
Grant·A
Director
$0
5.8K sh
Own New
-
Grant·A
Director
$0
5.8K sh
Own New
-
Exercise·M
Executive VP RA, QA
$0
75 sh
Own New
-
Other·F
Executive VP RA, QA
$1.0K
26 sh · $39.90
Own -3%
-
Exercise·M
Executive VP RA, QA
$0
75 sh
Own +9%
-
Grant·A
VP GM Advanced Surgical
$0
11.6K sh
Own New
-
Grant·A
VP GM Advanced Surgical
$0
9.8K sh
Own New
-
Grant·A
John D. Ferrell KEY
Executive Vice President - HR
$0
11.0K sh
Own New
-
Grant·A
John D. Ferrell KEY
Executive Vice President - HR
$0
9.3K sh
Own New
-
Grant·A
Treasurer and VP, Tax
$0
5.9K sh
Own New
-
Grant·A
EVP, STRAT & CORP DEVT
$0
11.0K sh
Own New
-
Grant·A
EVP, STRAT & CORP DEVT
$0
9.3K sh
Own New
-
Grant·A
Executive VP RA, QA
$0
11.3K sh
Own New
-
Grant·A
Executive VP RA, QA
$0
9.6K sh
Own New
-
Grant·A
General Counsel & Corp Sec
$0
12.9K sh
Own New
-
Grant·A
General Counsel & Corp Sec
$0
10.9K sh
Own New
-
Grant·A
VP Corporate Controller
$0
5.9K sh
Own New
-
Grant·A
Executive VP RA, QA
$0
17.2K sh
Own New
-
Grant·A
VP GM Advanced Surgical
$0
17.5K sh
Own New
-
Grant·A
General Counsel & Corp Sec
$0
18.6K sh
Own New
-
Grant·A
John D. Ferrell KEY
Executive Vice President - HR
$0
16.9K sh
Own New
-
Grant·A
EVP, STRAT & CORP DEVT
$0
16.9K sh
Own New
-
Exercise·M
Director
$0
152 sh
Own New
-
Exercise·M
Director
$0
152 sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 2, 2026 | Laverne H Council | Exercise M | 668 | $0 |
| Jun 2, 2026 | Laverne H Council | Exercise M | 668 | $0 |
| Jun 2, 2026 | Charles Farkas | Exercise M | 668 | $0 |
| Jun 2, 2026 | Charles Farkas | Exercise M | 668 | $0 |
| Jun 2, 2026 | Mark Kaye | Exercise M | 668 | $0 |
| Jun 2, 2026 | Mark Kaye | Exercise M | 668 | $0 |
| Jun 2, 2026 | Barbara J Schwarzentraub | Exercise M | 668 | $0 |
| Jun 2, 2026 | Barbara J Schwarzentraub | Exercise M | 668 | $0 |
| Jun 2, 2026 | David M. Bronson | Exercise M | 668 | $0 |
| Jun 2, 2026 | David M. Bronson | Exercise M | 668 | $0 |
| Jun 1, 2026 | Laverne H Council | Grant A | 5.8K | $0 |
| Jun 1, 2026 | Kim Kelderman | Grant A | 5.8K | $0 |
| Jun 1, 2026 | Charles Farkas | Grant A | 5.8K | $0 |
| Jun 1, 2026 | Mark Kaye | Grant A | 5.8K | $0 |
| Jun 1, 2026 | Barbara J Schwarzentraub | Grant A | 5.8K | $0 |
| Jun 1, 2026 | David M. Bronson | Grant A | 5.8K | $0 |
| Mar 6, 2026 | Brent Lalomia | Exercise M | 75 | $0 |
| Mar 6, 2026 | Brent Lalomia | Other F | 26 | $1.0K |
| Mar 6, 2026 | Brent Lalomia | Exercise M | 75 | $0 |
| Mar 2, 2026 | Matthew Schabacker | Grant A | 11.6K | $0 |
| Mar 2, 2026 | Matthew Schabacker | Grant A | 9.8K | $0 |
| Mar 2, 2026 | John D. Ferrell KEY | Grant A | 11.0K | $0 |
| Mar 2, 2026 | John D. Ferrell KEY | Grant A | 9.3K | $0 |
| Mar 2, 2026 | Johonna Marie Pelletier | Grant A | 5.9K | $0 |
| Mar 2, 2026 | Peter K Shagory | Grant A | 11.0K | $0 |
| Mar 2, 2026 | Peter K Shagory | Grant A | 9.3K | $0 |
| Mar 2, 2026 | Brent Lalomia | Grant A | 11.3K | $0 |
| Mar 2, 2026 | Brent Lalomia | Grant A | 9.6K | $0 |
| Mar 2, 2026 | Hollie K Foust | Grant A | 12.9K | $0 |
| Mar 2, 2026 | Hollie K Foust | Grant A | 10.9K | $0 |
| Mar 2, 2026 | Andrew James Moller | Grant A | 5.9K | $0 |
| Mar 2, 2026 | Brent Lalomia | Grant A | 17.2K | $0 |
| Mar 2, 2026 | Matthew Schabacker | Grant A | 17.5K | $0 |
| Mar 2, 2026 | Hollie K Foust | Grant A | 18.6K | $0 |
| Mar 2, 2026 | John D. Ferrell KEY | Grant A | 16.9K | $0 |
| Mar 2, 2026 | Peter K Shagory | Grant A | 16.9K | $0 |
| Feb 24, 2026 | Mark Kaye | Exercise M | 152 | $0 |
| Feb 24, 2026 | Mark Kaye | Exercise M | 152 | $0 |
About CNMD insider trading
This page tracks insider transactions for CONMED Corp (CNMD) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.